granisetron has been researched along with Kahler Disease in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Console, G; Ferreri, A; Gentile, M; Gori, M; Loteta, B; Martino, M; Morabito, A; Moscato, T; Naso, V; Paviglianiti, A; Pitino, AL; Porto, G; Provenzano, PF; Rossi, M; Tripepi, G | 1 |
| Iida, H; Kojima, Y; Matsumoto, S; Miyazawa, K; Nagai, H; Nakamura, A | 1 |
| Burhenne, J; Egerer, G; Freiberger, A; Goldschmidt, H; Gronkowski, M; Ho, AD; Hüsing, J; Mikus, G; Neben, K; Pelzl, le H; Schmitt, T; Thalheimer, M | 1 |
| Belkacémi, Y; Gorin, NC; Laporte, JP; Laugier, A; Ozsahin, M; Pène, F; Rio, B; Sutton, L; Touboul, E | 1 |
| Araújo Pereira, ME; Carmo, JA; Juncal, C; Lacerda, JF; Lacerda, JM; Lourenço, MF; Martins, C; Rodrigues, A | 1 |
2 trial(s) available for granisetron and Kahler Disease
| Article | Year |
|---|---|
Aprepitant, granisetron, and dexamethasone for prevention of chemotherapy-induced nausea and vomiting after high-dose melphalan in autologous transplantation for multiple myeloma: results of a randomized, placebo-controlled phase III trial.
Topics: Aprepitant; Dexamethasone; Double-Blind Method; Granisetron; Hematopoietic Stem Cell Transplantation; Humans; Melphalan; Morpholines; Multiple Myeloma; Nausea; Prospective Studies; Quality of Life; Transplantation, Autologous; Vomiting | 2014 |
Randomized trial of ondansetron, granisetron, and tropisetron in the prevention of acute nausea and vomiting.
Topics: Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Granisetron; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppression Therapy; Indoles; Leukemia; Male; Multiple Myeloma; Myelodysplastic Syndromes; Nausea; Ondansetron; Transplantation, Autologous; Transplantation, Homologous; Tropisetron; Vomiting | 2000 |
3 other study(ies) available for granisetron and Kahler Disease
| Article | Year |
|---|---|
Granisetron transdermal system and dexamethasone for the prevention of nausea and vomiting in multiple myeloma patients receiving chemo-mobilization: An observational real-world study of effectiveness and safety.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Dexamethasone; Female; Granisetron; Humans; Male; Middle Aged; Multiple Myeloma; Nausea; Prospective Studies; Vomiting; Young Adult | 2020 |
Clinical Impact of Aprepitant in Patients Receiving High-Dose Chemotherapy prior to Autologous Peripheral Blood Stem Cell Transplantation: A Cost-Effectiveness Analysis.
Topics: Adult; Aged; Antineoplastic Agents; Aprepitant; Cost-Benefit Analysis; Female; Granisetron; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Morpholines; Multiple Myeloma; Nausea; Peripheral Blood Stem Cell Transplantation; Retrospective Studies; Vomiting | 2017 |
Total body irradiation prior to bone marrow transplantation: efficacy and safety of granisetron in the prophylaxis and control of radiation-induced emesis.
Topics: Adolescent; Adult; Age Factors; Antiemetics; Body Weight; Bone Marrow Transplantation; Diuresis; Dose-Response Relationship, Drug; Female; Granisetron; Humans; Leukemia; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multiple Myeloma; Multivariate Analysis; Sex Factors; Whole-Body Irradiation | 1996 |